Saruwatari J, Yasui-Furukori N, Niioka T, Akamine Y, Takashima A, Kaneko S, Uno T.
Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.
J Clin Psychopharmacol 32, 195-199, 2012.

Saruwatari J, Deguchi M, Yoshimori Y, Noai M, Yoshida S, Ogusu N, Oniki K, Yoshida S, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagawa K.
Superoxide dismutase 2 Val16Ala polymorphism is a risk factor for the valproic acid-related elevation of serum aminotransferases.
Epilepsy Res 99, 183-186, 2012.

Saruwatari J, Takaishi C, Yoshida K, Takashima A, Fujimura Y, Umemoto Y, Abe T, Kitamado M, Shimomasuda M, Muramoto Y, Nakagawa K.
A herbal-drug interaction study of keishi-bukuryo-gan, a traditional herbal preparation used for menopausal symptoms, in healthy female volunteers.
J Pharm Pharmacol 64, 670-676, 2012.

Haerian BS, Baum L, Tan HJ, Kwan P, Raymond AA, Saruwatari J, Nakagawa K, Mohamed Z.
SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study.
Pharmacogenomics 13, 1477-1485, 2012.

Kimura M, Shimizu M, Kiyotani K, Nakagawa K, Kamataki T, Yamazaki H.
Cytochrome P450 2A6 phenotyping based on dietary caffeine intake in a Japanese population of non-smokers.
Drug Metab Lett 6, 67-72, 2012.